These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1267851)

  • 1. Inhibition of vitamin K epoxidase by two non-coumarin anticoagulants.
    Willingham AK; Laliberte RE; Bell RG; Matschiner JT
    Biochem Pharmacol; 1976 May; 25(9):1063-6. PubMed ID: 1267851
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport.
    Lowenthal J; Birnbaum H
    Science; 1969 Apr; 164(3876):181-3. PubMed ID: 5774189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of vitamin K dependent carboxylation by tetrachloropyridinol and the imidazopyridines.
    Friedman PA; Griep AE
    Biochemistry; 1980 Jul; 19(14):3381-6. PubMed ID: 6773541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide.
    Ren P; Stark PY; Johnson RL; Bell RG
    J Pharmacol Exp Ther; 1977 Jun; 201(3):541-6. PubMed ID: 864593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coumarins and the vitamin K-K epoxide cycle. Lack of resistance to coumatetralyl in warfarin-resistant rats.
    Bell RG; Caldwell PT; Holm EE
    Biochem Pharmacol; 1976 May; 25(9):1067-70. PubMed ID: 1267852
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
    Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A
    Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant-resistant rats: possible control by the use of the chloro analog of vitamin K 1 .
    Suttie JW
    Science; 1973 May; 180(4087):741-3. PubMed ID: 4702571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K antagonism of coumarin intoxication in the rat.
    Wallin R; Patrick SD; Ballard JO
    Thromb Haemost; 1986 Apr; 55(2):235-9. PubMed ID: 2424118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of antagonism of vitamin K by anticoagulants.
    Nutr Rev; 1978 Sep; 36(9):289-91. PubMed ID: 714310
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of action of coumarins. Significance of vitamin K epoxide.
    Sadowski JA; Suttie JW
    Biochemistry; 1974 Aug; 13(18):3696-9. PubMed ID: 4853124
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of vitamin K and prothrombin synthesis: anticoagulants and the vitamin K--epoxide cycle.
    Bell RG
    Fed Proc; 1978 Oct; 37(12):2599-604. PubMed ID: 359368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of liver microsomal epoxide hydrase by cyproheptadine epoxide.
    Pachecka J; Salmona M; Belvedere G; Cantoni L; Mussini E; Garattini S
    Experientia; 1977 Apr; 33(4):484-5. PubMed ID: 862740
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of prothrombin synthesis and epoxidation of vitamin K1 by anticoagulants in vitro.
    Bell RG; Stark P
    Biochem Biophys Res Commun; 1976 Sep; 72(2):619-25. PubMed ID: 985502
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of ticrynafen potentiation of coumarin anticoagulant action.
    Preusch PC; Suttie JW
    Biochem Pharmacol; 1983 Aug; 32(16):2393-8. PubMed ID: 6615542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Hutson SM
    Trends Mol Med; 2004 Jul; 10(7):299-302. PubMed ID: 15242675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of competitive vitamin K antagonist, 2-chloro-3-phytyl-1,4-naphthoquinone, for the study of the mechanism of action of vitamin K and coumarin anticoagulants.
    Lowenthal J; MacFarlane JA
    J Pharmacol Exp Ther; 1967 Sep; 157(3):672-80. PubMed ID: 6048023
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitamin K requirement and warfarin tolerance in the hamster.
    Shah DV; Suttie JW
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):126-8. PubMed ID: 1187683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-Dihydroxyvitamin D3 promotes vitamin K2 metabolism in human osteoblasts.
    Miyake N; Hoshi K; Sano Y; Kikuchi K; Tadano K; Koshihara Y
    Osteoporos Int; 2001; 12(8):680-7. PubMed ID: 11580082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.